BSG
Basic information
Region (hg38): 19:571277-583494
Previous symbols: [ "OK" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Blood group, OK | BG | Hematologic | Variants associated with a blood group may be important in specific situations (eg, related to transfusion) | Hematologic | 9130641 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BSG gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 13 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 5 | |||||
Total | 0 | 0 | 13 | 5 | 9 |
Variants in BSG
This is a list of pathogenic ClinVar variants found in the BSG region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-571546-C-A | BSG-related disorder | Likely benign (Mar 05, 2019) | ||
19-572645-C-G | not specified | Uncertain significance (Aug 17, 2022) | ||
19-577782-G-T | BSG-related disorder | Benign (Feb 02, 2024) | ||
19-577793-G-A | BSG-related disorder | Likely benign (Feb 21, 2019) | ||
19-578072-G-A | BSG-related disorder | Likely benign (May 23, 2019) | ||
19-579492-C-T | Likely benign (Dec 28, 2018) | |||
19-579514-A-G | not specified | Uncertain significance (Feb 14, 2023) | ||
19-579519-C-T | Benign (Dec 18, 2018) | |||
19-579528-C-T | BSG-related disorder | Likely benign (Apr 09, 2019) | ||
19-579604-G-C | not specified | Uncertain significance (Dec 12, 2023) | ||
19-579608-G-C | not specified | Uncertain significance (Feb 13, 2023) | ||
19-579620-A-G | not specified | Uncertain significance (Dec 27, 2023) | ||
19-579627-C-T | BSG-related disorder | Benign (Oct 31, 2019) | ||
19-580388-C-G | BSG-related disorder | Benign (Oct 31, 2019) | ||
19-580428-G-A | BLOOD GROUP--OK | Affects (Apr 01, 1997) | ||
19-580441-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
19-580662-G-T | not specified | Uncertain significance (Apr 23, 2024) | ||
19-580665-T-C | BSG-related disorder | Benign (Oct 21, 2019) | ||
19-580710-G-A | BSG-related disorder | Benign (Feb 28, 2019) | ||
19-580756-T-C | not specified | Uncertain significance (Jan 29, 2024) | ||
19-581364-G-T | not specified | Uncertain significance (Jun 22, 2023) | ||
19-581367-G-A | not specified | Uncertain significance (May 23, 2023) | ||
19-581371-A-G | Benign (Dec 31, 2019) | |||
19-581385-A-G | not specified | Uncertain significance (Oct 10, 2023) | ||
19-581466-C-T | not specified | Uncertain significance (Feb 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BSG | protein_coding | protein_coding | ENST00000333511 | 8 | 12197 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000259 | 0.929 | 125152 | 0 | 16 | 125168 | 0.0000639 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.143 | 254 | 248 | 1.03 | 0.0000171 | 2458 |
Missense in Polyphen | 73 | 96.374 | 0.75746 | 1000 | ||
Synonymous | -2.93 | 155 | 115 | 1.35 | 0.00000926 | 766 |
Loss of Function | 1.68 | 10 | 17.6 | 0.568 | 8.32e-7 | 192 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000172 | 0.000158 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000838 | 0.0000798 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000103 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an important role in targeting the monocarboxylate transporters SLC16A1, SLC16A3, SLC16A8 and SLC16A11 to the plasma membrane. Plays pivotal roles in spermatogenesis, embryo implantation, neural network formation and tumor progression. Stimulates adjacent fibroblasts to produce matrix metalloproteinases (MMPS). Seems to be a receptor for oligomannosidic glycans. In vitro, promotes outgrowth of astrocytic processes. {ECO:0000269|PubMed:17127621, ECO:0000269|PubMed:28666119}.;
- Pathway
- Matrix Metalloproteinases;Integrin cell surface interactions;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Bile salt and organic anion SLC transporters;Extracellular matrix organization;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Proton-coupled monocarboxylate transport;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Transport of small molecules;Cell surface interactions at the vascular wall;Hemostasis;Degradation of the extracellular matrix;Basigin interactions;Syndecan-1-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.358
Intolerance Scores
- loftool
- 0.593
- rvis_EVS
- -1.04
- rvis_percentile_EVS
- 7.71
Haploinsufficiency Scores
- pHI
- 0.156
- hipred
- Y
- hipred_score
- 0.588
- ghis
- 0.471
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.930
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bsg
- Phenotype
- immune system phenotype; respiratory system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); endocrine/exocrine gland phenotype;
Zebrafish Information Network
- Gene name
- bsg
- Affected structure
- head
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- pyruvate metabolic process;homophilic cell adhesion via plasma membrane adhesion molecules;cell surface receptor signaling pathway;axon guidance;embryo implantation;monocarboxylic acid transport;extracellular matrix disassembly;extracellular matrix organization;odontogenesis of dentin-containing tooth;response to peptide hormone;response to mercury ion;decidualization;leukocyte migration;response to cAMP;dendrite self-avoidance;protein localization to plasma membrane
- Cellular component
- Golgi membrane;acrosomal membrane;mitochondrion;plasma membrane;integral component of plasma membrane;focal adhesion;membrane;axon;sarcolemma;melanosome;intracellular membrane-bounded organelle;membrane raft;extracellular exosome
- Molecular function
- protein binding;mannose binding;monocarboxylic acid transmembrane transporter activity;cadherin binding;cell-cell adhesion mediator activity